Fundraising FoxJude Gomila — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ali Ozes(Founder)inOsman Ozes(Founder)inJAMES BREITMEYER(Executive Officer, Director)ERIC BJERKHOLT(Director)MIKE GREY(Director)ESTER SKLARSKY(Director)
Co-investorsCreative Destruction Lab (CDL)Tachyon VenturesY CombinatorFshd Global Research Foundation
Ultra manufactures OP1, a stationary multi-purpose AI robot for warehouse automation that handles repetitive tasks like packing, sorting, and kitting.
Advanced ManufacturingAI & Machine LearningLogistics & Supply ChainRoboticsNew York City, US
Jon Miller Schwartz(CEO)inMax Friefeld(Founder)inChetan Parthiban(Founder)inJonathan Schwartz(Executive Officer, Director)inOliver Ortlieb(CTO)inEric Drymer(Founder)
Co-investorsMaiora Rebel VenturesNextView VenturesNirman InvestmentsPioneerRebel FundY Combinator+14 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.